Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2003
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467831A1 Mint extract and related pharmaceutical compositions
06/05/2003CA2467734A1 Composition based on diosgenin ester for topical use
06/05/2003CA2467647A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/04/2003EP1316306A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316305A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316304A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316303A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316302A1 Cosmetic and/or dermatological composition containing at least one oxidation sensitive hydrophilic active stabilised by at least one polymer or copolymer of N-vinylimidazole
06/04/2003EP1316301A1 Cosmetic or dermatological composition containing a retinoid and/or a carotenoid and acexamic acid
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315741A2 A method for treating allergies
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315498A2 Use of ectoin or ectoin derivatives for stabilizing p53
06/04/2003EP1315496A2 The treatment of inflammatory disorders
06/04/2003EP1315476A2 Nitric oxide-producing hydrogel materials
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1214347B1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
06/04/2003EP1159061A4 Chemical method for making pyrithione particle dispersions
06/04/2003EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP0969821B1 Pellets having a core coated with an antifungal and a polymer
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0859838B1 Novel procollagens
06/04/2003EP0817641B1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422158A Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422146A Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials
06/04/2003CN1421230A Granulation promoting and pus drawing out ointment
06/04/2003CN1421218A Sweeling-eliminating medicine powder
06/04/2003CN1421216A Sore ulcer treating medicine powder
06/04/2003CN1421210A Cell growth regulating factor P and its prepn process
06/04/2003CN1421205A Compound prepn for promoting growth of hair
06/04/2003CN1421198A Skin moistening and itch stopping bath dew and its prepn
06/04/2003CN1421197A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421196A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421195A Composition containing N-vinyl iminazole polymer of copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421194A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421193A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421192A Recipe and prepn process of skin care article
06/04/2003CN1110559C Gene for regulating aureobasidin sensitivity
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110477C 1,25-dihydroxy-16,22,23-trisdehydro-chdecalciferol derivatives
06/04/2003CN1110316C Black plaster and preparing process thereof
06/04/2003CN1110309C Medicine for treating psoriasis and its preparing process
06/04/2003CN1110307C Medicine for curing tinea unguium
06/04/2003CN1110302C Oxyacid and related compounds for treating skin disease
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573297 (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same
06/03/2003US6573293 Anticancer agents
06/03/2003US6573265 Preventing or treating diseases caused by free radicals of the cellular oxygen metabolism, stimulating nerve cell growth, antagonizing glutamate receptors and/or stimulating the growth notably of glutamergic nerve cells; anticarcinogenic agents;
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6572857 Psoriasis; humanized sub clone of IOR T1A produced by the hybridoma deposited with ECACC, CAMR under accession number 96112640, having heavy and light chains with humanized variable regions.
06/03/2003US6572848 Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
06/03/2003CA2273446C Piperidones
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044080A1 Water-in-silicone emulsions
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 1065